In anticipation of the upcoming 79
th
annual ADA, we would like to share some exciting news with you. We have had a tremendous year of innovation and achievement, driven by our unwavering commitment to improving the health and quality of life of our patients while providing the highest levels of quality and service to our research partners. Additionally, we will be participating at several of this year’s sessions and are greatly looking forward to connecting with you during the meeting in San Francisco, California!
|
LMC Healthcare
is Canada's largest Specialist Care provider in Diabetes & Endocrinology with a team of over 55 Endocrinologists across 12 sites caring for more than 77,000 active patients. This new model encompasses 6 services (Diabetes & Endocrinology, Diabetes Education, Diabetes Pharmacy, Chiropody, Optometry and Clinical Research) under one roof.
We’re dedicated to transforming diabetes specialist care by making it more accessible, comprehensive and patient-centric than ever before.
|
LMC Manna Research
is an industry leader, providing Phase I-IV clinical trial services at 20 active research sites across Canada. It is the largest clinical research site group in the country and one of the largest research site networks in the world. The company is also the world’s largest group specialized in diabetes, lipid, metabolic and endocrinology research. Over the past 20 years, the company has completed more than 1,800 studies to help evaluate hundreds of new drugs and treatments in more than 18,000 patients, across more than 35 therapeutic areas. LMC Manna Research has won numerous awards for performance, quality, and innovation in its commitment to improving the health and welfare of patients - making healthy easier.
Follow us on twitter
@LMCManna
#MakingHealthyEasier
|
April marked the launch of
hyperCORE International
, a Super Network of highly awarded and experienced Clinical Research Site Organizations.
LMC Manna Research is a founding alliance partner. It forms the
second largest site network in the world
with
more than 80 sites across 5 countries on 2 continents.
Its unique ownership model combines the strengths of 8 leading independent research site companies under one umbrella focusing on agility and innovation to accelerate clinical research through centralization of core operations and innovative strategic partnerships with Sponsors/CROs.
Read the news release here, and be sure to add and follow on social media:
|
LMC Manna Research has also been invited to join an elite group of vaccine sites,
VaxCorps
. This marks the first international expansion of the organization and allows clients to leverage a larger, high-performing group spanning both Canada and the USA.
|
Recent Awards:
ACRP All-Star Site Challenge Winner:
LMC Manna, as part of the hyperCORE International team at the ACRP 2019 conference, won the award competing amongst the industry’s top research sites.
ACRP / Devana Solutions Annual Site Metrics Challenge: Fastest Feasibility Turnaround
|
Noteworthy:
Following an engaging session on
Big Data, Real World Evidence
at the recent ACRP Conference,
Karri Venn
was featured as a key opinion leader in an Outsourcing Pharma article: Patients, Data, and making it all work together: Using RWD in Research.
|
EMR/EHR Innovation
LMC Manna Research’s innovative approach of next generation query functions on EMR/EHR data was highlighted in an article published by Cambridge Innovation Institute: Building a Research Grade EMR from the Ground Up. Karri discussed the evolution and rationale of building one of the industry’s most sophisticated patient database systems to further patient engagement and enhance clinical research as part of the circle of care.
Read the full article here:
http://www.clinicalinformaticsnews.com/2019/05/23/building-a-research-grade-emr-from-the-ground-up.aspx
|
Spotlight on Quality
Karri Venn was invited to join the
AVOCA Quality Congress
, part of the
Avoca Quality Consortium (AQC)
, a collaborative comprised of nearly 100 pharma, biotech, CRO, and clinical service provider companies with the shared objective of elevating clinical trial quality and bringing key stakeholders in the clinical trials process into greater alignment.
LMC Manna Research is proud to be actively contributing and leading in various quality initiatives such as AQC, in our unwavering commitment to continuous quality improvement across the entire clinical research continuum.
|
2019 ADA Abstracts and Presentations
|
Chief Medical Officer
Dr. Ronnie Aronson
, along with members of the
LMC Healthcare
&
LMC Manna Research
teams will be presenting their findings in multiple poster presentations and abstracts during the course of the conference.
For a complete list of our poster presentations and current abstracts at ADA 2019,
click here.
|
Come visit us at booth #2105
! Looking forward to hearing from you soon.
Regards,
The Team at LMC Healthcare & LMC Manna Research
Ronnie Aronson
Chief Medical Officer
Karri Venn
President, Research
647-274-4133
|
|
